182 related articles for article (PubMed ID: 3484714)
1. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.
Willems B; Villeneuve JP; Huet PM
Hepatology; 1986; 6(1):92-7. PubMed ID: 3484714
[TBL] [Abstract][Full Text] [Related]
2. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
[TBL] [Abstract][Full Text] [Related]
3. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
Bosch J; Enriquez R; Groszmann RJ; Storer EH
Hepatology; 1983; 3(6):1002-7. PubMed ID: 6629314
[TBL] [Abstract][Full Text] [Related]
4. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol.
Braillon A; Moreau R; Hadengue A; Roulot D; Sayegh R; Lebrec D
J Hepatol; 1989 Nov; 9(3):312-8. PubMed ID: 2607120
[TBL] [Abstract][Full Text] [Related]
5. Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo.
Pomier-Layrargues G; Villeneuve JP; Willems B; Huet PM; Marleau D
Gastroenterology; 1987 Dec; 93(6):1218-24. PubMed ID: 3315825
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of propranolol on portal venous pressure.
Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
[TBL] [Abstract][Full Text] [Related]
7. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
8. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
9. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Hadengue A; Moreau R; Cerini R; Koshy A; Lee SS; Lebrec D
Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
[TBL] [Abstract][Full Text] [Related]
10. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
[TBL] [Abstract][Full Text] [Related]
12. Systemic and hepatic hemodynamics in hepatosplenic Manson's schistosomiasis with and without propranolol.
Mies S; Neto OB; Beer A; Baía CE; Alfieri F; Pereira LM; Sette MJ; Raia S
Dig Dis Sci; 1997 Apr; 42(4):751-61. PubMed ID: 9125644
[TBL] [Abstract][Full Text] [Related]
13. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
[TBL] [Abstract][Full Text] [Related]
14. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
16. The effect of propranolol on the hyperaemic response of the hepatic artery to portal venous occlusion in the dog.
Alexander B; Blumgart LH; Mathie RT
Br J Pharmacol; 1989 Feb; 96(2):356-62. PubMed ID: 2538190
[TBL] [Abstract][Full Text] [Related]
17. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
Castaño G; Viudez P; Riccitelli M; Sookoian S
Ann Hepatol; 2003; 2(1):36-40. PubMed ID: 15094704
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
20. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
